← FDA Drug Approvals (Drugs@FDA)
GANIRELIX ACETATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AMPHASTAR PHARMS INC · Approved 2022-04-07
Drug application
- FDA Application #
ANDA212613- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- GANIRELIX ACETATE
- Generic name
- GANIRELIX ACETATE
- Active ingredients
- GANIRELIX ACETATE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- AMPHASTAR PHARMS INC
- Manufacturer
- Amphastar Pharmaceuticals, Inc.
- First approval
- 2022-04-07
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown